| Balance Sheets | 2025-10-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 434 | |||
| Accounts receivable | 389 | |||
| Inventories, net | 237 | |||
| Restricted cash | 75 | |||
| Prepaid expenses | 41 | |||
| Total current assets | 1,176 | |||
| Property, plant and equipment, net | 10 | |||
| Total assets | 1,186 | |||
| Accounts payable | 879 | |||
| Convertible notes payable to related parties, current-Related Party | 2,104 | |||
| Accrued liabilities | 176 | |||
| Total current liabilities | 3,159 | |||
| Convertible notes payable to related parties, non-current-Related Party | 3,573 | |||
| Total liabilities | 6,732 | |||
| Common stock, 0.01 par value 200,000,000 shares authorized, 111,886,473 shares issued and outstanding at october 31, 2025, and july 31, 2025 | 1,119 | |||
| Additional paid-in capital | 132,793 | |||
| Accumulated deficit | -139,458 | |||
| Total stockholders deficiency | -5,546 | |||
| Total liabilities and stockholders deficiency | 1,186 | |||
PURE BIOSCIENCE, INC. (PURE)
PURE BIOSCIENCE, INC. (PURE)